Essex Woodlands Management, Inc. Long-Term Concentrated

Location: The Woodlands, TX

CIK: 0001542339 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 13, 2014

Total Value: $481M (100.0% shares, 0.0% debt)

Holdings (11)

— REVANCE THERAPEUTICS INC 32.5%

Value $156M Shares 4,592,047 Est. Cost $31.50 Unrealized —

— HORIZON PHARMA INC 18.5%

Value $88.98M Shares 5,815,940 Est. Cost $2.26 Unrealized —

— ABIOMED INC 16.5%

Value $79.19M Shares 3,150,000 Est. Cost $21.56 Unrealized —

— CORIUM INTL INC 15.1%

Value $72.67M Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 12.5%

Value $60.07M Shares 2,814,936 Est. Cost $18.00 Unrealized —

— ACURA PHARMACEUTICALS INC 2.2%

Value $10.66M Shares 10,284,886 Est. Cost $1.82 Unrealized —

— ZIOPHARM ONCOLOGY INC 2.1%

Value $10.26M Shares 2,764,908 Est. Cost $1.96 Unrealized —

MNOV MEDICINOVA INC 0.5%

Value $2.376M Shares 1,170,370 Est. Cost $2.95 Unrealized -33.9%

— CURIS INC 0.1%

Value $435K Shares 233,797 Est. Cost $3.19 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value $28,000 Shares 12,319 Est. Cost $2.52 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value $24,000 Shares 23,928 Est. Cost $0.59 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	4,592,047	$156M	32.5%	$31.50	—	COM	761330109
—	HORIZON PHARMA INC	5,815,940	$88.98M	18.5%	$2.26	—	COM	44047T109
—	ABIOMED INC	3,150,000	$79.19M	16.5%	$21.56	—	COM	003654100
—	CORIUM INTL INC	9,353,304	$72.67M	15.1%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	2,814,936	$60.07M	12.5%	$18.00	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	10,284,886	$10.66M	2.2%	$1.82	—	COM NEW	00509L703
—	ZIOPHARM ONCOLOGY INC	2,764,908	$10.26M	2.1%	$1.96	—	COM	98973P101
MNOV	MEDICINOVA INC	1,170,370	$2.376M	0.5%	$2.95	-33.9%	COM NEW	58468P206
—	CURIS INC	233,797	$435K	0.1%	$3.19	—	COM	231269101
—	ECHO THERAPEUTICS INC	12,319	$28,000	0.0%	$2.52	—	COM NEW	27876L206
—	PALATIN TECHNOLOGIES INC	23,928	$24,000	0.0%	$0.59	—	COM PAR $ .01	696077403